About AB4AD (Antibodies for Alzheimer's Disease)

Ab4AD (Antibodies for Alzheimer’s Disease) is a research initiative from Dr. Daniel Z. Bar (Tel Aviv University) that investigates the pathogen hypothesis of Alzheimer’s: common infections (notably herpes and P. gingivalis) appear to modulate AD risk. The team will analyze blood and saliva from dementia-free elderly individuals and compare them to AD patients and younger controls to identify protective antibodies. Instead of only targeting protein aggregation, Ab4AD focuses on why some exposed individuals stay dementia-free, using their natural antibody profiles as blueprints for protection. Funded and tracked through Molecule Catalyst, enabling visible milestones and community governance via IP Tokens (IPTs).

2/8/2026, 8:49:28 AM

Trading Insights

Traders

1

Market Stats

Market Cap

$40.76K

FDV

$40.76K

Circ. Supply

1M AB4AD

Max Supply

1M AB4AD

Total Supply

1M AB4AD

Diluted Valuation

$48.67K

Performance

Popularity

Not enough data

Dominance

0%

Volume (24H)

$718.64

Volume (7D)

Not enough data

Volume (30D)

Not enough data

All time high

$0.0487

Price Change (1Y)

Not enough data

88.42%

Predict sports, crypto, politics, culture & more.

Explore predictionsExplore
Offered by Coinbase Financial Markets
Prediction Markets Promo Banner Image
Offered by Coinbase Financial Markets

Additional details

Market details

AB4AD vs markets

↘ 85%

AB4AD vs BTC

↘ 84.13%

AB4AD vs ETH

↘ 85.54%

Tags

0

Network & Addresses

Network
Address

Base

0x57414656AC535680367f519eeC9f0D7Ffe99e2D0

Price history

Time
Price
Change
Today
$0.0487
0.00%
1 Day
$0.0487
0.00%
1 Week
$0.12
-59.95%
1 Month
$0.15
-68.16%
1 Year
$0.42
-88.42%

FAQ

We update our AB4AD (Antibodies for Alzheimer's Disease) to USD currency in real-time. Get the live price of AB4AD (Antibodies for Alzheimer's Disease) on Coinbase.

The current market cap of AB4AD (Antibodies for Alzheimer's Disease) is $40.755K. A high market cap implies that the asset is highly valued by the market.

The all-time high of AB4AD (Antibodies for Alzheimer's Disease) is $0.0487. This all-time high is highest price paid for AB4AD (Antibodies for Alzheimer's Disease) since it was launched.

Over the last 24 hours, the trading volume of AB4AD (Antibodies for Alzheimer's Disease) is $718.64.

Assets that have a similar market cap to AB4AD (Antibodies for Alzheimer's Disease) include Chimpzee (CHMPZ), xDai Bridged USDT (Gnosis), HUG, and many others. To see a full list, see our comparable market cap assets.

The current circulating supply of AB4AD (Antibodies for Alzheimer's Disease) is 1 million.

Guides

AB4AD (Antibodies for Alzheimer's Disease) calculator

Related assets

Legal